STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

OKLAHOMA MEDICAL RESEARCH FOUNDATION: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
OKLAHOMA MEDICAL RESEARCH FOUNDATION (EIN 73-0580274)
Tax period
2018-07-01 to 2019-06-30
Filed
2020-06-24
IRS object ID
202041769349301219
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-06-24T12:00:39-05:00ReturnTs
Tax Period End2019-06-30TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2018-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN730580274EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlOKLABusinessNameControlTxt
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonTim HassenPersonNm
Person TitleVP and Chief Financial OfficerPersonTitleTxt
Signature2020-06-24SignatureDt
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and CFOBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$207,118,901GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.omrf.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1946FormationYr
Legal Domicile StateOKLegalDomicileStateCd
Activity Or MissionOklahoma Medical Research Foundation (OMRF) is dedicated to developing a better understanding of and more effective treatments for human disease.ActivityOrMissionDesc
Voting Members Governing Body71VotingMembersGoverningBodyCnt
Voting Members Independent71VotingMembersIndependentCnt
Total Employee560TotalEmployeeCnt
Total Volunteers71TotalVolunteersCnt
Total Gross UBI$82,071TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$72,373NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$58,406,493PYContributionsGrantsAmt
CY Contributions Grants$60,132,921CYContributionsGrantsAmt
PY Program Service Revenue$23,054,835PYProgramServiceRevenueAmt
CY Program Service Revenue$24,773,802CYProgramServiceRevenueAmt
PY Investment Income$4,679,205PYInvestmentIncomeAmt
CY Investment Income$5,386,846CYInvestmentIncomeAmt
PY Other Revenue$5,642,641PYOtherRevenueAmt
CY Other Revenue$6,231,501CYOtherRevenueAmt
PY Total Revenue$91,783,174PYTotalRevenueAmt
CY Total Revenue$96,525,070CYTotalRevenueAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$37,608,837PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$38,524,021CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$2,024,579CYTotalFundraisingExpenseAmt
PY Other Expenses$51,600,819PYOtherExpensesAmt
CY Other Expenses$51,008,364CYOtherExpensesAmt
PY Total Expenses$89,209,656PYTotalExpensesAmt
CY Total Expenses$89,532,385CYTotalExpensesAmt
PY Revenues Less Expenses$2,573,518PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$6,992,685CYRevenuesLessExpensesAmt
Total Assets BOY$404,739,259TotalAssetsBOYAmt
Total Assets EOY$415,080,137TotalAssetsEOYAmt
Total Liabilities BOY$55,574,718TotalLiabilitiesBOYAmt
Total Liabilities EOY$55,619,740TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$349,164,541NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$359,460,397NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOMRF is dedicated to developing a better understanding of more effective treatments for human disease.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$35,297,853ExpenseAmt
Grant$0GrantAmt
Revenue$24,773,802RevenueAmt
DescArthritis and Clinical Immunology/Clinical Operations - The National Institutes of Health once again named OMRF an Autoimmunity Center of Excellence, one of only 10 in the U.S. With this designation comes funding to design and launch new clinical trials for patients with diseases like lupus, rheumatoid arthritis and multiple sclerosis. Those trials include: * Testing medications to prevent the onset of lupus and RA * A pair of experimental therapies targeted at reversing damage caused by MS * A study designed to assess when it might be safe to stop lupus treatments that carry potentially toxic side effects in patients whose disease has wanedDesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$6,482,700ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescCardiovascular Biology Research Program - In November, the FDA announced it had approved a new drug to treat sickle cell disease. The therapy, known as Adakveo, is based on discoveries made in OMRF's Cardiovascular Biology Research Program. Approval came following a 52-week clinical trial showing treatment with the drug led to a significant reduction in pain crises for sickle cell patients. The blood disorder, which affects more than 1 million people worldwide, causes excruciating pain and can lead to organ damage and even death. "I've treated people with sickle cell disease, and their suffering is extreme," says Dr. Rodger McEver, the OMRF researcher upon whose work the new drug is based. "It's the dream of every physician, and certainly every scientist, to do something that can make a difference with patients."Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$4,168,723ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescAging and Metabolism Research Program - Scientists in this program study a host of different disease processes, but their work unites in a common theme: building knowledge to extend the healthspan of our aging population. In 2019, they progressed toward this goal in a variety of ways. One scientist received funding from the National Institutes of Health for novel experiments to investigate whether the brain chemical dopamine plays a role in Alzheimer's disease. Another initiated a pair of multi-year projects designed to understand osteoarthritis, with an emphasis on the effects of aging, diet and trauma in the knee joint. Finally, in a study highlighted by The New York Times, work in this program showed that, despite hope to the contrary, the widely-used diabetes drug metformin doesn't seem to be a magic bullet that will counter the effects of aging.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

FieldValueIRS element (for citing)
Expense$36,884,296ExpenseAmt
Grant$0GrantAmt
Revenue$3,996,673RevenueAmt
DescOTHER PROGRAM SERVICES INCLUDE DEPARTMENTS SUCH AS CELL CYCLE AND CANCER BIOLOGY, FUNCTIONAL AND CHEMICAL GENOMICS, LABORATORY OF COAGULATION BIOLOGY AND OTHER SCIENTIFIC AND RESEARCH SUPPORT SERVICES.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$36,884,296TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Revenue$3,996,673TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$82,833,572TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsYes (true)TaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountYes (true)EscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (true)BusinessRlnWithFamMemInd
Business Rln With Officer EntYes (true)BusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityYes (true)DisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document151IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee560EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsYes (true)NondeductibleContributionsInd
Nondeductible Contri DisclYes (true)NondeductibleContriDisclInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OfYes (true)Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form8899 FiledindtrueForm8899Filedind
Form1098 C FiledYes (true)Form1098CFiledInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members71GoverningBodyVotingMembersCnt
Independent Voting Member71IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd
OtherYes (X)OtherInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Tim Hassen VP and Chief Financial OfficerBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4052717421PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (88 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Albers Leigh Ann
Board Member1.0Yes (X)$0$0$0
Anoatubby Bill
Board Member1.0Yes (X)$0$0$0
Bell Sharon
Board Member1.0Yes (X)$0$0$0
Benbrook Bruce
Board Member1.0Yes (X)$0$0$0
Benham Lance
Board Member1.0Yes (X)$0$0$0
Boghetich JII
Board Member1.0Yes (X)$0$0$0
Braught Barbara
Board Member1.0Yes (X)$0$0$0
Brown Rand
Board Member1.0Yes (X)$0$0$0
Burgess Ellen
Board Member1.0Yes (X)$0$0$0
Carolina Mike
Board Member1.0Yes (X)$0$0$0
Carroll MichaeL
Board Member1.0Yes (X)$0$0$0
Cason Len
Board Member1.0Yes (X)$0$0$0
Cawley Michael
Board Member1.0Yes (X)$0$0$0
Champlin Hiram
Board Member1.0Yes (X)$0$0$0
Collins Mark
Board Member1.0Yes (X)$0$0$0
Drake Ramsey
Board Member1.0Yes (X)$0$0$0
Duncan Walt
Board Member1.0Yes (X)$0$0$0
Eagan Claire
Board Member1.0Yes (X)$0$0$0
Edwards Carl
Board Member1.0Yes (X)$0$0$0
Everest Christy
Board Member1.0Yes (X)$0$0$0
Everest Tricia
Board Member1.0Yes (X)$0$0$0
Felton Ann
Board Member1.0Yes (X)$0$0$0
Fergeson Ken
Board Member1.0Yes (X)$0$0$0
Fischer Malinda
Board Member1.0Yes (X)$0$0$0
Funke Mark
Board Member1.0Yes (X)$0$0$0
Gamble Gerald
Board Member1.0Yes (X)$0$0$0
Griffin John
Board Member1.0Yes (X)$0$0$0
Groendyke Viritinia
Board Member1.0Yes (X)$0$0$0
Haglund Jacqul
Board Member1.0Yes (X)$0$0$0
Hall Brooks
Board Member1.0Yes (X)$0$0$0
Hargis Burns
Board Member1.0Yes (X)$0$0$0
Hatfield Judy
Board Member1.0Yes (X)$0$0$0
Hawley Bill
Board Member1.0Yes (X)$0$0$0
Henry Kim
Board Member1.0Yes (X)$0$0$0
Hogan Randy
Board Member1.0Yes (X)$0$0$0
Holmes Jerome
Board Member1.0Yes (X)$0$0$0
Hudson Cliff
Board Member1.0Yes (X)$0$0$0
Irani Ronnie
Board Member1.0Yes (X)$0$0$0
Jameson Brett
Board Member1.0Yes (X)$0$0$0
Johnstone Bill
Board Member1.0Yes (X)$0$0$0
Kelly Michael
Board Member1.0Yes (X)$0$0$0
Kern Terence
Board Member1.0Yes (X)$0$0$0
Kerr Lou
Board Member1.0Yes (X)$0$0$0
Levx Harrison
Board Member1.0Yes (X)$0$0$0
Little Dan
Board Member1.0Yes (X)$0$0$0
Loughridge Bill
Board Member1.0Yes (X)$0$0$0
Mahaney Mindy
Board Member1.0Yes (X)$0$0$0
McCarty Jack
Board Member1.0Yes (X)$0$0$0
Morris Jim
Board Member1.0Yes (X)$0$0$0
Nichols Larry
Board Member1.0Yes (X)$0$0$0
Parry Richard
Board Member1.0Yes (X)$0$0$0
Patten Rebecca
Board Member1.0Yes (X)$0$0$0
Payne Bond
Board Member1.0Yes (X)$0$0$0
Pierson Gary
Board Member1.0Yes (X)$0$0$0
Pitman Don
Board Member1.0Yes (X)$0$0$0
Pollard Barry
Board Member1.0Yes (X)$0$0$0
Rainbolt David
Board Member1.0Yes (X)$0$0$0
Replogle Dee
Board Member1.0Yes (X)$0$0$0
Rooney Pat
Board Member1.0Yes (X)$0$0$0
Ross Bob
Board Member1.0Yes (X)$0$0$0
Samis Mike
Board Member1.0Yes (X)$0$0$0
Saxon John
Board Member1.0Yes (X)$0$0$0
Schulte Paul
Board Member1.0Yes (X)$0$0$0
Stougn Phyllis
Board Member1.0Yes (X)$0$0$0
Swimmer Ross
Board Member1.0Yes (X)$0$0$0
Switzer Becky
Board Member1.0Yes (X)$0$0$0
Taylor Steven
Board Member1.0Yes (X)$0$0$0
Thorpe Beisy
Board Member1.0Yes (X)$0$0$0
Walton Greg
Board Member1.0Yes (X)$0$0$0
Williams G Rainey Jr
Board Member1.0Yes (X)$0$0$0
Yauk Sarah
Board Member1.0Yes (X)$0$0$0
Prescott Stephen
President and CEO50.0$1,063,348$0$42,060Yes (X)
James Judith
VP of Clinical Affairs and Program Chair50.0$458,846$0$100,061Yes (X)
McEver Rodger
VP of Research and Member50.0$328,321$0$41,145Yes (X)
Morgan Chip
Executive VP & Chief Operating Officer50.0$254,462$0$39,772Yes (X)
Cohen Adam
Sr VP and General Counsel50.0$256,486$0$43,153Yes (X)
Hassen Tim
VP and CFO50.0$246,235$0$50,562Yes (X)
Voss Penny
VP of Development50.0$222,877$0$62,431Yes (X)
Nair Manu
VP of Technology Transfer50.0$233,856$0$44,153Yes (X)
Courtney Greenwood
VP of Human Resources50.0$158,483$0$33,352Yes (X)
Day Lisa
VP of Business and Government Affairs50.0$136,110$0$21,207Yes (X)
Pardo Gabriel
Associate Member, Arthritis and Clinical Immunoid50.0$335,185$0$47,123Yes (X)
Xia Lijun
Program Chair and Cardiovascular Biology50.0$277,637$0$67,943Yes (X)
Jones David
Program Chair, Functional and Chemical Genomics50.0$306,251$0$47,123Yes (X)
Gaffney Patrick
Program Chair, Arthritis and Clinical Immunology50.0$301,896$0$57,242Yes (X)
Nath Swapan
Member, Arthritis and Clinical Immunology50.0$263,452$0$48,126Yes (X)
Rezale Alizera
Member, Cardiovascular Biology50.0$249,527$0$39,084Yes (X)
Lupu Florea
Member, Cardiovascular Biology50.0$246,815$0$32,863Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,339,787TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$817,400TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K59IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (4 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Infusion Management LLC
11233 Shadow Creek PwkyPearlandTX77584Medical Billing Services$17,973,886
Aramark
24863 Network PlChicagoIL606731248HouseKeeping Services$513,837
Mcallister & Quinn LLC
1368 N Washington AveScrantonPA18509Grant application review services$152,000
Exaptive Inc
309 NW 13th StOklahoma CityOK73103Pilot research project assistance$125,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K4CntrctRcvdGreaterThan100KCnt
Federated Campaigns$103,776FederatedCampaignsAmt
Fundraising$540,331FundraisingAmt
Government Grants$31,452,033GovernmentGrantsAmt
All Other Contributions$28,036,781AllOtherContributionsAmt
Noncash Contributions$861,639NoncashContributionsAmt
Total Contributions$60,132,921TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescClinic RevenueDesc
Business621990BusinessCd
Total Revenue Column$24,773,802TotalRevenueColumnAmt
Related Or Exempt Func Income$24,773,802RelatedOrExemptFuncIncomeAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$24,773,802TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$11,442,564TotalRevenueColumnAmt
Unrelated Business Revenue$14,360UnrelatedBusinessRevenueAmt
Exclusion$11,428,204ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$116,278TotalRevenueColumnAmt
Exclusion$116,278ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,330,094TotalRevenueColumnAmt
Related Or Exempt Func Income$1,684,970RelatedOrExemptFuncIncomeAmt
Exclusion$1,645,124ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$374,255RealAmt
Personal$0PersonalAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$374,255RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$374,255TotalRevenueColumnAmt
Exclusion$374,255ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$102,746,070SecuritiesAmt
Other$1,544,002OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$109,913,636SecuritiesAmt
Other$548,432OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$7,167,566SecuritiesAmt
Other$995,570OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$6,171,996TotalRevenueColumnAmt
Unrelated Business Revenue$67,711UnrelatedBusinessRevenueAmt
Exclusion-$6,239,707ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$64,604FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$540,331ContriRptFundraisingEventAmt
Fundraising Direct Expenses$131,763FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$67,159TotalRevenueColumnAmt
Exclusion-$67,159ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtExclusionExclusionAmt
Laboratory Income621500$2,311,703$2,311,703
Cafe Income722514$282,608$282,608

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$2,594,311OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$96,525,070TotalRevenueColumnAmt
Related Or Exempt Func Income$28,770,475RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$82,071UnrelatedBusinessRevenueAmt
Exclusion$7,539,603ExclusionAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$3,971,844TotalAmt
Program Services$3,067,985ProgramServicesAmt
Management And General$680,982ManagementAndGeneralAmt
Fundraising$222,877FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$25,767,931TotalAmt
Program Services$23,744,284ProgramServicesAmt
Management And General$1,033,360ManagementAndGeneralAmt
Fundraising$990,287FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,670,164TotalAmt
Program Services$1,505,758ProgramServicesAmt
Management And General$96,276ManagementAndGeneralAmt
Fundraising$68,130FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$5,218,993TotalAmt
Program Services$4,512,401ProgramServicesAmt
Management And General$526,020ManagementAndGeneralAmt
Fundraising$180,572FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,895,089TotalAmt
Program Services$1,708,541ProgramServicesAmt
Management And General$109,242ManagementAndGeneralAmt
Fundraising$77,306FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$102,427TotalAmt
Program Services$72,733ProgramServicesAmt
Management And General$29,694ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$113,400TotalAmt
Management And General$113,400ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$64,455TotalAmt
Management And General$64,455ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,359,542TotalAmt
Program Services$1,359,542ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$568,395TotalAmt
Program Services$336,061ProgramServicesAmt
Management And General$77,608ManagementAndGeneralAmt
Fundraising$154,726FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,184,544TotalAmt
Program Services$970,986ProgramServicesAmt
Management And General$174,781ManagementAndGeneralAmt
Fundraising$38,777FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$3,780,448TotalAmt
Program Services$3,012,626ProgramServicesAmt
Management And General$767,744ManagementAndGeneralAmt
Fundraising$78FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$770,419TotalAmt
Program Services$680,356ProgramServicesAmt
Management And General$63,522ManagementAndGeneralAmt
Fundraising$26,541FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$133,217TotalAmt
Program Services$132,451ProgramServicesAmt
Management And General$766ManagementAndGeneralAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$886,015TotalAmt
Program Services$870,766ProgramServicesAmt
Management And General$15,249ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$7,829,195TotalAmt
Program Services$7,489,289ProgramServicesAmt
Management And General$339,906ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$301,008TotalAmt
Program Services$213,744ProgramServicesAmt
Management And General$87,264ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
Lab supplies$6,042,285$6,042,285
Trainee costs$1,183,320$1,183,320
Inhouse$1,693,521$1,657,918$22,491$13,112
Subcontracts$22,432,503$22,432,503

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,563,670TotalAmt
Program Services$1,840,023ProgramServicesAmt
Management And General$471,474ManagementAndGeneralAmt
Fundraising$252,173FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$89,532,385TotalAmt
Program Services$82,833,572ProgramServicesAmt
Management And General$4,674,234ManagementAndGeneralAmt
Fundraising$2,024,579FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$4,200BOYAmt
EOY$3,640EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$22,699,110BOYAmt
EOY$20,330,349EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$6,573,788BOYAmt
EOY$8,527,729EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$4,945,865BOYAmt
EOY$5,264,915EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$102,500BOYAmt
EOY$52,500EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$13,070BOYAmt
EOY$12,735EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$288,761BOYAmt
EOY$524,743EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$234,948,705LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$136,682,537LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$100,420,755BOYAmt
EOY$98,266,168EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$110,679,441BOYAmt
EOY$121,232,724EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$13,632,479BOYAmt
EOY$15,002,777EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$145,379,290BOYAmt
EOY$145,861,857EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$404,739,259BOYAmt
EOY$415,080,137EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$10,458,467BOYAmt
EOY$13,066,821EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$1,795,563BOYAmt
EOY$1,060,576EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$37,605,000BOYAmt
EOY$34,810,000EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$5,715,688BOYAmt
EOY$6,682,343EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$55,574,718BOYAmt
EOY$55,619,740EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$113,467,709BOYAmt
EOY$120,292,368EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$42,961,441BOYAmt
EOY$45,807,340EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$192,735,391BOYAmt
EOY$193,360,689EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$349,164,541BOYAmt
EOY$359,460,397EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$404,739,259BOYAmt
EOY$415,080,137EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$6,992,685ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$2,934,671NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$368,500OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$51,509,291CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$55,448,766CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$58,391,949CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,406,493CurrentTaxYearMinus1YearAmt
Current Tax Year$60,132,921CurrentTaxYearAmt
Total$283,889,420TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$51,509,291CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$55,448,766CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$58,391,949CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$58,406,493CurrentTaxYearMinus1YearAmt
Current Tax Year$60,132,921CurrentTaxYearAmt
Total$283,889,420TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$49,978,828SubstantialContributorsTotAmt
Public Support Total170$233,910,592PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,537,705CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$6,651,582CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$6,182,195CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$8,549,189CurrentTaxYearMinus1YearAmt
Current Tax Year$13,575,846CurrentTaxYearAmt
Total$41,496,517TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,304CurrentTaxYearMinus1YearAmt
Current Tax Year$81,073CurrentTaxYearAmt
Total$86,377TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$724,249CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$287,716CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$732,460CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$334,103CurrentTaxYearMinus1YearAmt
Current Tax Year$347,212CurrentTaxYearAmt
Total$2,425,740TotalAmt
FieldValueIRS element (for citing)
Total Support$327,898,054TotalSupportAmt
Gross Receipts Rltd Activities$87,973,722GrossReceiptsRltdActivitiesAmt
Public Support CY1700.7134PublicSupportCY170Pct
Public Support PY1700.7317PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10 Other IncomeFormAndLineReferenceDesc
ExplanationDESCRIPTION - , COLUMN A - 724249.0, COLUMN B - 287716.0, COLUMN C - 732460.0, COLUMN D - 334103.0, COLUMN E - 347212.0, COLUMN F - 2425740.0;ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsYes (true)DirectContactLegislatorsInd
Direct Contact Legislators$420,331DirectContactLegislatorsAmt
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesfalseOtherActivitiesInd
Total Lobbying Expenditures$420,331TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITYFormAndLineReferenceDesc
ExplanationThe Foundation's lobbying activities entail monitoring proposed legislation and educating legislators and their staffs about the Foundation, medical research and the impact of proposed legislation on medical research and the Foundation.ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$97,512,842BeginningYearBalanceAmt
Contributions$16,719,850ContributionsAmt
Investment Earnings Or Losses$5,906,286InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,200,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$115,938,978EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$91,545,136BeginningYearBalanceAmt
Contributions$75,342ContributionsAmt
Investment Earnings Or Losses$9,892,364InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,000,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$97,512,842EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$82,018,035BeginningYearBalanceAmt
Contributions$246,125ContributionsAmt
Investment Earnings Or Losses$13,280,976InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$4,000,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$91,545,136EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$86,604,791BeginningYearBalanceAmt
Contributions$389,217ContributionsAmt
Investment Earnings Or Losses-$1,175,973InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$3,800,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$82,018,035EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$86,302,560BeginningYearBalanceAmt
Contributions$1,057,014ContributionsAmt
Investment Earnings Or Losses$2,745,217InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$3,500,000OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$86,604,791EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.2232BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.4766PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.3002TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgYes (true)EndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,944,520OtherCostOrOtherBasisAmt
Book Value$3,944,520BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$183,335,585OtherCostOrOtherBasisAmt
Depreciation$101,311,594DepreciationAmt
Book Value$82,023,991BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$47,049,478OtherCostOrOtherBasisAmt
Depreciation$35,370,943DepreciationAmt
Book Value$11,678,535BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$619,122OtherCostOrOtherBasisAmt
Book Value$619,122BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$98,266,168TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (8 entries)

DescDescBook ValueBookValueAmt
Funds held in trust by others$137,793,022
Wills and Bequests$3,620,090
Cash Surrender Value of Life Insurance$3,940,291
Debt Issue Costs$208,013
Deposits$123,847
Accrued Interest Receivable$128,515
Assets Held for Sale$47,970
Minerals$109
FieldValueIRS element (for citing)
Total Book Value Other Assets$145,861,857TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
Postretirement Benefits and Deferred Comp$6,560,962
Split Interest Agreements$121,381
FieldValueIRS element (for citing)
Total Liability$6,682,343TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$99,828,241TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$2,934,671NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Recoveries Prior Year Grants$0RecoveriesPriorYearGrantsAmt
Other Revenue$368,500OtherRevenueAmt
Revenue Not Reported$3,303,171RevenueNotReportedAmt
Revenue Subtotal$96,525,070RevenueSubtotalAmt
Investment Expenses Not Incld$0InvestmentExpensesNotIncldAmt
Other Revenues Not Included$0OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$96,525,070TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$89,532,385TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$0DonatedServicesUseFcltsAmt
Prior Year Adjustments$0PriorYearAdjustmentsAmt
Losses Reported$0LossesReportedAmt
Other Expenses Included$0OtherExpensesIncludedAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$89,532,385ExpensesSubtotalAmt
Investment Expenses Not Incld2$0InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$0OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$89,532,385TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part V, Line 4 Intended uses of endowment fundsThe Foundation's endowment consists of individual funds established to provide the Foundation with funding in perpetuity.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnoteThe Foundation is a public foundation exempt from federal income tax under section 501(c)(3) of the internal revenue code except for amounts relating to unrelated business income. There were no known material unrelated business income taxes incurred in 2019 and accordingly, no provision for income taxes has been made in these financial statements. Management has reviewed the Foundation's tax position and concluded that there are no uncertain tax positions that require accrual in the consolidated financial statements or disclosure in the footnotes to be in compliance with authoritative literature. Generally, the Foundation is no longer subject to income tax examination by federal, state or local tax authorities for years prior to 2016. The statute of limitations will remain open for both federal and state purposes for any returns not filed.
Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990Changes in fair value of Funds Held in Trust - 498639 Pension related changes other than net periodic pension costs - -130139

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmtSpecific Services ProvidedSpecificServicesProvidedTxt
East Asia and the Pacific06Conference Travel$16,350
Europe (Including Iceland and Greenland)021Conference Travel$81,632
Europe (Including Iceland and Greenland)01Program Services$2,770Program Project Review
North America (Canada & Mexico only)09Conference Travel$14,107
South America02Conference Travel$3,414
South Asia01Program Services$2,867Intellectual Property/Research Collaboration
Europe (Including Iceland and Greenland)015,Education$25,026
North America (Canada & Mexico only)01,Board Relations$2,171
North America (Canada & Mexico only)00Investments$677,147
Central America and the Caribbean00Investments$667,703
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees56SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee56TotalEmployeeCnt
Subtotal Spent$1,493,187SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,493,187TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (true)ForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 3FormAndLineReferenceDesc
ExplanationProgram service activity in all regions includes scientists attending and/or speaking at scientific conferences and collaborations. OMRF does not maintain ongoing operations in foreign jurisdictions, however the Foundation's scientists do travel to various scientific conferences in other countries to share in scientific discoveries, as well as to learn from other scientists across the world.ExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1241 EventEvent1Nm
Gross Receipts Event1$604,935GrossReceiptsEvent1Amt
Charitable Contri Event1$540,331CharitableContriEvent1Amt
Gross Revenue Event1$64,604GrossRevenueEvent1Amt
Non Cash Prizes Event1$7,920NonCashPrizesEvent1Amt
Rent Facility Costs Event1$19,210RentFacilityCostsEvent1Amt
Food And Beverage Event1$17,892FoodAndBeverageEvent1Amt
Entertainment Event1$36,130EntertainmentEvent1Amt
Other Direct Expenses Event1$50,611OtherDirectExpensesEvent1Amt
Gross Revenue Event2$0GrossRevenueEvent2Amt
Gross Revenue Other Events$0GrossRevenueOtherEventsAmt
Gross Receipts Total$604,935GrossReceiptsTotalAmt
Charitable Contributions Tot$540,331CharitableContributionsTotAmt
Gross Revenue Total Events$64,604GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$7,920NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$19,210RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$17,892FoodAndBeverageTotalEventsAmt
Entertainment Total Events$36,130EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$50,611OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$131,763DirectExpenseSummaryEventsAmt
Net Income Summary-$67,159NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Travel For CompanionsYes (X)TravelForCompanionsInd
Discretionary Spending AcctYes (X)DiscretionarySpendingAcctInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (true)AnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (17 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Prescott Stephen
President and CEO$795,327$0$223,979$0$44,042$0$30,356$0$11,704$0$1,105,408$0$0$0
James Judith
VP of Clinical Affairs and Program Chair$405,599$0$9,375$0$43,872$0$89,408$0$10,653$0$558,907$0$0$0
McEver Rodger
VP of Research and Member$277,610$0$6,792$0$43,919$0$30,041$0$11,104$0$369,466$0$0$0
Morgan Chip
Executive VP & Chief Operating Officer$216,679$0$10,268$0$27,515$0$26,236$0$13,536$0$294,234$0$0$0
Cohen Adam
Sr VP and General Counsel$200,816$0$10,510$0$45,160$0$32,885$0$10,268$0$299,639$0$0$0
Hassen Tim
VP and CFO$222,403$0$10,360$0$13,472$0$32,060$0$18,502$0$296,797$0$0$0
Voss Penny
VP of Development$193,321$0$9,114$0$20,442$0$44,704$0$17,727$0$285,308$0$0$0
Nair Manu
VP of Technology Transfer$204,601$0$9,375$0$19,880$0$26,693$0$17,460$0$278,009$0$0$0
Courtney Greenwood
VP of Human Resources$147,661$0$6,542$0$4,280$0$16,802$0$16,550$0$191,835$0$0$0
Day Lisa
VP of Business and Government Affairs$123,704$0$5,579$0$6,827$0$11,214$0$9,993$0$157,317$0$0$0
Pardo Gabriel
Associate Member, Arthritis and Clinical Immunoid$333,913$0$0$0$1,272$0$29,671$0$17,452$0$382,308$0$0$0
Xia Lijun
Program Chair and Cardiovascular Biology$251,808$0$125$0$25,704$0$50,491$0$17,452$0$345,580$0$0$0
Jones David
Program Chair, Functional and Chemical Genomics$305,279$0$0$0$972$0$29,671$0$17,452$0$353,374$0$0$0
Gaffney Patrick
Program Chair, Arthritis and Clinical Immunology$287,084$0$100$0$14,712$0$39,790$0$17,452$0$359,138$0$0$0
Nath Swapan
Member, Arthritis and Clinical Immunology$239,140$0$0$0$24,312$0$30,014$0$18,112$0$311,578$0$0$0
Rezale Alizera
Member, Cardiovascular Biology$206,052$0$0$0$43,475$0$26,913$0$12,171$0$288,611$0$0$0
Lupu Florea
Member, Cardiovascular Biology$201,940$0$0$0$44,875$0$26,040$0$6,823$0$279,678$0$0$0

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 3Compensation for the CEO is determined by leadership of the board of directors based on comparability data from widely accepted peer benchmarking surveys that are segmented by region and size of entity.
Schedule J, Part I, Line 1a First-class or charter travelFirst class travel is allowed for the CEO to allow him to accomplish work related to tasks while traveling.
Schedule J, Part I, Line 1a Travel for companionsTravel for companions is allowed in certain limited circumstances where the companion's presence has a benefit to the Foundation but does not qualify as a business expense under IRS rules. In those limited cases the companion's travel expenses are treated as taxable compensation.
Schedule J, Part I, Line 1a Discretionary spending accountAlso, the CEO can expend up to $10,000 per fiscal year in additional compensation for reimbursement of non-qualified business expenses.
Schedule J, Part I, Line 4b Supplemental nonqualified retirement planThe Board of the Foundation periodically uses non-qualified retirement plans as a retention tool. The amount reported is the amount vested in the 457(f) plan. The remaining amount of the plan is not vested and is subject to substantial risk of forfeiture.
Schedule J, Part I, Line 7 Non-fixed paymentsThe CEO receives an annual bonus that is determined by leadership of the board of directors based on performance. The bonus is considered as a portion of total compensation and is subject to the review process previously described.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (2 entries)

Bond ReferenceBondReferenceCdBond Issuer EINBondIssuerEINCUSIPCUSIPNumBond IssuedBondIssuedDtIssue PriceIssuePriceAmtPurposePurposeDescDefeasedDefeasedIndOn Behalf Of IssuerOnBehalfOfIssuerIndPool FinancingPoolFinancingInd
Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2010
A7361943550000000002010-05-26$12,185,000Refunding of Prior year 2001 bondfalsefalsefalse
Oklahoma Industries Authority Revenue Bonds (OMRF Project) Series 2016
B7361943550000000002016-07-13$29,535,000Refunding of prior year 2008 bondfalsefalsefalse

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (2 entries)

Bond ReferenceBondReferenceCdRetiredRetiredAmtBond DefeasedBondDefeasedAmtTotal ProceedsTotalProceedsAmtIn Reserve FundInReserveFundAmtCapitalized InterestCapitalizedInterestAmtRefunding EscrowRefundingEscrowAmtIssuance Costs From ProceedsIssuanceCostsFromProceedsAmtCredit EnhancementCreditEnhancementAmtWorking Capital ExpendituresWorkingCapitalExpendituresAmtCapital ExpendituresCapitalExpendituresAmtOther Spent ProceedsOtherSpentProceedsAmtUnspentUnspentAmtSubstantial CompletionSubstantialCompletionYrRefunding Tax Exempt BondsRefundingTaxExemptBondsIndRefunding Taxable BondsRefundingTaxableBondsIndFinal Allocation MadeFinalAllocationMadeIndAdequate Books And Rec MaintAdequateBooksAndRecMaintInd
A$0$0$12,185,000$96,500$0$11,946,495$142,005$0$0$0$0$02010Yes (true)Yes (true)Yes (true)Yes (true)
B$6,910,000$0$29,535,000$2,953,564$0$26,315,325$266,175$0$0$0$0$02016falseYes (true)Yes (true)Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (2 entries)

Bond ReferenceBondReferenceCdOwning Bond Financed PropertyOwningBondFinancedPropertyIndAny Lease ArrangementsAnyLeaseArrangementsIndMgmt Contract Bond Fincd PropMgmtContractBondFincdPropIndAny Research AgreementsAnyResearchAgreementsIndEngage Bond Counsel ResearchEngageBondCounselResearchIndPrivate Bus Use By OthersPrivateBusUseByOthersPctPrivate Bus Concerning UBIPrivateBusConcerningUBIPctTotal Private Business UseTotalPrivateBusinessUsePctBond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestIndChange In Use Bond Financed PropChangeInUseBondFinancedPropIndProcs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
AfalsefalsefalseYes (true)Yes (true)0.00.00.0falsefalseYes (true)
BfalsefalsefalseYes (true)Yes (true)0.00.00.0falsefalseYes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (2 entries)

Bond ReferenceBondReferenceCdForm8038 T FiledForm8038TFiledIndVariable Rate IssueVariableRateIssueIndHedge Identified In Bks And RecHedgeIdentifiedInBksAndRecIndGross Proceeds Invested In GICGrossProceedsInvestedInGICIndGross Proceeds InvestedGrossProceedsInvestedIndWritten Proc To Monitor ReqsWrittenProcToMonitorReqsIndRebate Not Due YetRebateNotDueYetIndException To RebateExceptionToRebateIndNo Rebate DueNoRebateDueInd
AYes (true)falsefalsefalsefalseYes (true)
BfalsefalsefalsefalsefalseYes (true)Yes (true)falsefalse

Procedures Corrective Action ProceduresCorrectiveActionGrp (2 entries)

Bond ReferenceBondReferenceCdProcedures Corrective ActionProceduresCorrectiveActionInd
AYes (true)
BYes (true)

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule K, Part I 05/26/2010 12185000 Oklahoma Industries AuthorityIn May 2010, the Foundation issued 12,185,000 of Oklahoma Industrial Authorities ("OIA") Series 2010 Revenue Bonds (the "Series 2010 Bonds") dated May 1, 2010. The proceeds from the Series 2010 Bonds were used to retire the OIA 2001 Series Bonds on February 1, 2011. The Series 2010 Bonds mature February 1, 2021 and bear interest at the stated rate of 4.375% per annum. Interest payments began July 1, 2010 and are due on August 1st and February 1st of each year through 2021, at which time the principal will be due in its entirety. The Series 2010 bonds were issued with no premium or discount. The Series 2010 Bond agreements also require maintenance of a reserve fund which is included in investments in the accompanying statement of financial position. This amount was approximately $1,218,400 as of June 30, 2019.
Schedule K, Part I 07/13/2016 29535000 Oklahoma Industries AuthorityIn July 2016, the Foundation entered into advanced refinancing of the Series 2008 bonds. The Foundation issued $43,955,000 of OIA Series 2008 Revenue Bonds (the "Series 2008 Bonds") dated July 1, 2008; the proceeds from this bond were used to construct and equip a new research facility. The Series 2008 Bonds were defeased when the Foundation issued $29,535,000 of OIA Series 2016 Revenue Bonds (the "Series 2016 Bonds") dated July 13, 2016. The Series 2016 bonds mature on July 1, 2026 and bear interest at the stated rate of 1.81% per annum. Payments of principal and interest began January 1, 2017 and are due January 1st and July 1st of each year. The Series 2016 Bond agreements also require maintenance of a reserve fund which is included in investments in the accompanying statement of financial position. This amount was $2,953,500 as of June 30, 2019.

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1Michelle MorganBusinessNameLine1Txt
FieldValueIRS element (for citing)
Relationship DescriptionRelated to OfficerRelationshipDescriptionTxt
Transaction$14,238TransactionAmt
TransactionEmploymentTransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution19ContributionCnt
Noncash Contributions Rpt F990$861,639NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, Line 4d Description of other program services(Expenses $ 36,884,296 including grants of $ 0)(Revenue $ 3,996,673) OTHER PROGRAM SERVICES INCLUDE DEPARTMENTS SUCH AS CELL CYCLE AND CANCER BIOLOGY, FUNCTIONAL AND CHEMICAL GENOMICS, LABORATORY OF COAGULATION BIOLOGY AND OTHER SCIENTIFIC AND RESEARCH SUPPORT SERVICES.
Form 990, Part VI, Line 1a Delegate broad authority to a committeeThe Foundation's Board of Directors has delegated all of its powers to the Foundation's Executive Committee, except as follows: establish the overall policies and direction of the Foundation, appoint members of the Executive Committee, elect and remove the Chair of the Board of Directors, amend the Bylaws and the Certificate of Incorporation of the Foundation, and appoint special committees to the Board of Directors. The Board of Directors may at any time amend or revoke this delegation of powers.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyThe Form 990 is prepared by the Foundation, internally reviewed by the CFO. The Form 990-T is externally reviewed by the tax department of a public accounting firm. A summary of Form 990 is presented for review to the Executive Committee. Subsequent to that review, the form 990 with all supplemental schedules is made available to all members of the board of directors for review and comment prior to filing.
Form 990, Part VI, Line 12c Conflict of interest policyEach director, officer and key employee is annually provided with a copy of the Foundation's conflict of interest policy. Each of these individuals is annually provided with a questionnaire regarding potential conflicts and required to disclose any potential conflict that he or she might have. In addition, each of these individuals must annually sign a statement affirming that he or she has; received a copy of the conflicts of interest policy, read and understood the policy and agrees to comply with the policy. Once the Foundation has collected annual disclosure statements from all directors, officer and key employees, the Foundation's Governance Committee reviews such information to identify situations in which a potential conflict exists and is material. If a potential material conflict is identified, the committee analyzes whether the contemplated transaction may be authorized as just, fair, and reasonable to the Foundation. The Governance Committee then makes a recommendation to the Foundations' Executive Committee regarding the management of all potential conflicts it has identified. The final decision as to the approval and, where applicable, management of all such potential conflict rests in the sole discretion of the Executive Committee, which makes such decisions based upon the welfare of the Foundation and the advancement of its purpose. The recommendations of the Governance Committee and decisions of the Executive Committee are documented in the respective minutes of these Committees' regular meetings.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer benchmarking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 15b Process to establish compensation of other employeesCompensation for officers and key employees is determined and evaluated in May of each year by the executive committee of the board of directors based on comparability data from widely accepted peer benchmarking salary surveys that are segmented by region and size of entity.
Form 990, Part VI, Line 18 How forms are made available to the publicThe Foundation's Form 990 for the last three years are publicly available on the Foundation's website, as well as on Guidestar and other nonprofit databases. Form 1023, 990, and 990-T are provided upon request.
Form 990, Part VI, Line 19 Required documents available to the publicThe Foundation's governing documents, conflict of interest policy, and financial statements are provided upon request and are publicly available on the foundation's website.
Form 990, Part XI, Line 9 Other changes in net assets or fund balancesOther changes in net assets or fund balances - 368500;
Form 990, Part VI Section A, Line 2The Foundation currently has 71 directors, many of whom are business leaders and members of prominent families in the State of Oklahoma. The Foundation believes there are multiple business relationships between and among board members and families of Board members, but the Foundation review of signed conflict of interest disclosures from all board members and of the Foundation's ledger accounts indicated there are no such relationships that would impair the fiduciary duties of any director to the Foundation.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1Culbertson Plaza LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1825 NE 13th StreetAddressLine1Txt
CityOklahoma CityCityNm
State AbbreviationOKStateAbbreviationCd
ZIP73104ZIPCd
FieldValueIRS element (for citing)
EIN842527142EIN
Primary ActivitiesManage real property known as the Culbertson Plaza Shopping CenterPrimaryActivitiesTxt
Legal Domicile StateOKLegalDomicileStateCd
Total Income$0TotalIncomeAmt
End Of Year Assets$50,000EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1Oklahoma Medical Research FoundationBusinessNameLine1Txt